Trial Profile
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 12 Feb 2024 Planned End Date changed from 30 Dec 2023 to 30 Jan 2025.
- 12 Feb 2024 Planned primary completion date changed from 30 Oct 2023 to 30 Oct 2024.
- 28 Apr 2023 Planned End Date changed from 30 Dec 2022 to 30 Dec 2023.